Nasdaq-listed company Enlivex Therapeutics plans to raise $212 million to establish the RAIN Token Treasury.

BlockBeats News, November 24th, according to The Block, Nasdaq-listed clinical-stage biopharmaceutical company Enlivex Therapeutics plans to raise $212 million through a private placement to create a digital asset reserve built around the prediction market token Rain — the world’s first publicly traded company asset reserve scheme centered around a prediction market token. Rain, self-described as a “fully decentralized prediction market protocol on the Arbitrum network,” allows users to create various event prediction markets in any language, determine outcomes through AI, and features a token buyback and burn mechanism.